Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ImmunityBio (IBRX) Inventory: 2017-2024

Historic Inventory for ImmunityBio (IBRX) over the last 3 years, with Dec 2024 value amounting to $8.3 million.

  • ImmunityBio's Inventory rose 242.34% to $6.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.7 million, marking a year-over-year increase of 242.34%. This contributed to the annual value of $8.3 million for FY2024, which is N/A change from last year.
  • Per ImmunityBio's latest filing, its Inventory stood at $8.3 million for FY2024, which was up 1,454.89% from $532,000 recorded in FY2018.
  • In the past 5 years, ImmunityBio's Inventory ranged from a high of $8.3 million in FY2024 and a low of $8.3 million during FY2024.
  • In the last 1 years, ImmunityBio's Inventory had a median value of $8.3 million in 2024 and averaged $8.3 million.